Cart
sales@molnova.com
Home - Products - Metabolic Enzyme/Protease - PPAR - L-165041

L-165041

CAS No. 79558-09-1

L-165041( —— )

Catalog No. M20696 CAS No. 79558-09-1

L-165041 is a potent and selective agonist of the nuclear receptor PPARβ and PPARδ(Ki = 9 nM EC50 = ~500 nM respectively).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 38 In Stock
5MG 50 In Stock
10MG 74 In Stock
25MG 160 In Stock
50MG 302 In Stock
100MG 506 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    L-165041
  • Note
    Research use only, not for human use.
  • Brief Description
    L-165041 is a potent and selective agonist of the nuclear receptor PPARβ and PPARδ(Ki = 9 nM EC50 = ~500 nM respectively).
  • Description
    L-165041 is a potent and selective agonist of the nuclear receptor PPARβ and PPARδ(Ki = 9 nM EC50 = ~500 nM respectively).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    PPAR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    79558-09-1
  • Formula Weight
    402.44
  • Molecular Formula
    C22H26O7
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:50 mg/mL (124.24 mM)
  • SMILES
    CCCc1c(OCCCOc2ccc(OCC(O)=O)cc2)ccc(C(C)=O)c1O
  • Chemical Name
    2-[4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy]-acetic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Park J H Lee K S Lim H J et al. The PPARδ ligand L-165041 inhibits vegf-induced angiogenesis but the antiangiogenic effect is not related to PPARδ[J]. Journal of Cellular Biochemistry 2012 113(6):1947-1954.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Arhalofenate

    Arhalofenate is a selective partial agonist of peroxisome proliferator-activated receptor PPARγ. It is used for the treatment of type 2 diabetes.

  • GW 501516

    A potent and subtype-selective PPARδ agonist with Ki of 1.1 nM in human PPARδ binding assay.

  • MK-0533

    MK-0533 is a novel PPARγ partial agonist for the prevention of vascular endothelial dysfunction (VED) and VED-related cardiovascular disease.

Sign In Join Free